The borderline association of dichotomised Ki672wk and the difficulty of implementing continuous variables as a tool in clinical practice underscores the importance to further investigate molecular markers as both predictive and prognostic tools in ER+/HER2+ BC. This evidence concerns the gene ESR1 and breast cancer.